Carson Wealth (CWM LLC)’s Crinetics Pharmaceuticals CRNX Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio CRNX Stock Details CRNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$5.34K	Sell	147 -26	-15%	-$1.16K	﹤0.01%	5001
2025 Q4	$8K	Buy	173 +87	+101%	+$3.87K	﹤0.01%	4624
2025 Q3	$4K	Sell	86 -322	-79%	-$10.3K	﹤0.01%	4798
2025 Q2	$12K	Sell	408 -15	-4%	-$463	﹤0.01%	4197
2025 Q1	$14K	Buy	423 +341	+416%	+$12.7K	﹤0.01%	3906
2024 Q4	$4K	Buy	82 +26	+46%	+$1.46K	﹤0.01%	4285
2024 Q3	$3K	Buy	56 +45	+409%	+$2.32K	﹤0.01%	4252
2024 Q2	$0	Buy	+11	New	+$508	﹤0.01%	4635
2023 Q4	–	Sell	-60	Closed	-$2K	–	4190
2023 Q3	$2K	Sell	60 -18	-23%	-$371	﹤0.01%	3775
2023 Q2	$1K	Buy	+78	New	+$1.55K	﹤0.01%	3936
2022 Q1	–	Sell	-22	Closed	-$1K	–	3566
2021 Q4	$1K	Buy	+22	New	+$542	﹤0.01%	3271

Other funds holding CRNX

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

DCM

Driehaus Capital Management Chicago, Illinois $17.3B AUM 211.34% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return

Carson Wealth (CWM LLC)'s CRNX Position: Q1 2026 in Review

Carson Wealth (CWM LLC) reduced its Crinetics Pharmaceuticals (CRNX) stake by 15% in Q1 2026, selling an estimated $1.16K and leaving 147 shares worth $5.34K. The position accounts for ﹤0.01% of the portfolio, ranked #5001.

Carson Wealth (CWM LLC) first reported a position in CRNX in Q4 2021 and has held it in 11 quarters since. The position peaked at $14K in Q1 2025. 243 funds tracked by Wall St. Rank hold CRNX as of Q1 2026.

Carson Wealth (CWM LLC) held 147 shares of Crinetics Pharmaceuticals worth $5.34K as of Q1 2026.
Carson Wealth (CWM LLC) sold 26 Crinetics Pharmaceuticals shares in Q1 2026, an estimated $1.16K.
Crinetics Pharmaceuticals made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #5001 holding.
Carson Wealth (CWM LLC) first reported a position in Crinetics Pharmaceuticals in Q4 2021 and has held it in 11 quarters since.
Carson Wealth (CWM LLC)'s Crinetics Pharmaceuticals position peaked at $14K in Q1 2025.
243 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.